TrimMedium
REFI remains in a sustained Stage 4 decline with lower highs and lower lows and price well below all key EMAs and SMAs. The medium-term bias is bearish, supported by distribution volume and lack of stabilization, while a short-term relief bounce has not yet tested or been rejected at resistance. We defer selling until price approaches falling EMAs or key overhead levels for a higher-probability entry.
- ↑16% annual dividend yield, $0.47 quarterly payout
- ↑Cannabis financing pipeline at $482M, $133M real-estate backed
- ↓10.7% of loan portfolio risk-rated four or higher
Full analysis →